In this case, radiation dermatitis (RD) is characterized by a differential response in 2 developmentally equivalent tissues from distinct anatomic locations.
Article InformationCorresponding Author: Mario E. Lacouture, MD, Dermatology Service, Memorial Sloan-Kettering Cancer Center, Rockefeller Outpatient Pavilion, Ste 228, 160 E 53rd St, New York, NY 10022 (email@example.com).
Published Online: August 6, 2014. doi:10.1001/jamadermatol.2014.888.
Conflict of Interest Disclosures: Dr Lacouture has served as a speaker, consultant, or advisor with Advancell, AstraZeneca, Aveo, Bayer, BergPharma, Bristol-Myers Squibb, Galderma, Genentech, Genzyme, GlaxoSmithKline, Helsinn, Imclone, Lilly, LindiSkin, Merck, Novocure, Novartis, Onyx, Pfizer, Roche, Sandoz, Sanofi Aventis and Wyeth. Dr Barker serves as a consultant to RP Pharmaceuticals.
Additional Contributions: We are indebted to Ying Zhou, MS, for assistance with in vivo dosimetry.